Skip to contentYeleswaram Krishnaswamy — Rapport Therapeutics, Inc. insider: 11 transactions · InsiderLensInsider trading activity of Yeleswaram Krishnaswamy
- Transactions on record
- 11
- since Jun 10, 2024
- Open-market buys
- 0
- Open-market sells
- 7
- $1.9M
- Companies traded
- 1
- last filing Apr 21, 2026
Figures computed from official regulatory filings — methodology.
Companies where Yeleswaram Krishnaswamy has traded
Track record of Yeleswaram Krishnaswamy
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Yeleswaram Krishnaswamy
Co-insiders of Yeleswaram Krishnaswamy
- ARCH Venture Fund XII, L.P.Rapport Therapeutics, Inc.
- ARCH Venture Partners XII, LLCRapport Therapeutics, Inc.
- ARCH Venture Partners XII, L.P.Rapport Therapeutics, Inc.
- Bredt DavidRapport Therapeutics, Inc.
- Burow KristinaRapport Therapeutics, Inc.
- Burrell Terry-AnnRapport Therapeutics, Inc.
- Ceesay AbrahamRapport Therapeutics, Inc.
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
CRANDELL KEITHRapport Therapeutics, Inc.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Apr 21, 2026 | Sell | -20,225 | 39.99 USD | $808.8K | SEC |
| Apr 14, 2026 | Sell | -10,200 | 35.08 USD | $357.8K | SEC |
| Apr 14, 2026 | Sell | -500 | 34.98 USD | $17.5K | SEC |
| Apr 14, 2026 | Sell | -9,165 | 34.97 USD | $320.5K | SEC |
| Apr 9, 2026 | Sell | -360 | 34.90 USD | $12.6K | SEC |
| Mar 26, 2026 | Sell | -10,115 | 29.99 USD | $303.3K | SEC |
| Feb 4, 2026 | AwardD | 120,000 | 0.00 USD | $0 | SEC |
| Jan 5, 2026 | Sell | -2,840 | 30.05 USD | $85.3K | SEC |
| Jan 5, 2026 | Award | 9,000 | — | — | SEC |
| Feb 4, 2025 | AwardD | 110,000 | 0.00 USD | $0 | SEC |
| Jun 10, 2024 | AwardD | 84,904 | 0.00 USD | $0 | SEC |